ALEXIS CHANTAL: Open Payments
NPI 1528013497 · BEDFORD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,259 in 66 payments from 10 companies in 2025. Trend: 2023 $886 · 2024 $754 · 2025 $1,259
Food & beverage: $1,198Education: $61
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 29 | $443 |
| ABBVIE INC. | 16 | $342 |
| GENZYME CORPORATION | 5 | $128 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $96 |
| Amgen Inc. | 5 | $79 |
| Arcutis Biotherapeutics, Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $37 |
| LEO Pharma Inc. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| PFIZER INC. | 1 | $14 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, OTEZLA, Zoryve, TALTZ, ILUMYA, ANZUPGO.
Industry payments across VA — which companies pay providers there.
